|Intel Core i7-3770K Ivy Bridge Processor|
|Reviews - Featured Reviews: Processors|
|Written by David Ramsey|
|Monday, 23 April 2012|
Page 7 of 19
CINEBENCH R11.5 Benchmarks
Maxon CINEBENCH is a real-world test suite that assesses the computer's performance capabilities. CINEBENCH is based on Maxon's award-winning animation software, Cinema 4D, which is used extensively by studios and production houses worldwide for 3D content creation. Maxon software has been used in blockbuster movies such as Spider-Man, Star Wars, The Chronicles of Narnia, and many more. CINEBENCH Release 11.5 includes the ability to more accurately test the industry's latest hardware, including systems with up to 64 processor threads, and the testing environment better reflects the expectations of today's production demands. A more streamlined interface makes testing systems and reading results incredibly straightforward.
The CINEBENCH R11.5 test scenario comprises three tests: an OpenGL-based test that models a simple car chase, and single-core and multi-core versions of a CPU-bound computation using all of a system's processing power to render a photo-realistic 3D scene, "No Keyframes", the viral animation by AixSponza. This scene makes use of various algorithms to stress all available processor cores, and all rendering is performed by the CPU: the graphics card is not involved except as a display device. The multi-core version of the rendering benchmark uses as many cores as the processor has, including the "virtual cores" in processors that support Hyper-Threading. The resulting "CineMark" is a dimensionless number only useful for comparisons with results generated from the same version of CINEBENCH.
I'm particulaly fond of CINEBENCH's multi-core rendering test, which highlights the performance advantages of more cores and Hyper Threading in an easy-to-appreciate visual manner. In multi-core rendering, the 3770K ekes out a mere 6% win, but its lead increases to 27% when overclocked. In the single-core rendering test, the percentages are 7.7% and 28.4%, respectively.